Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Adaptive Biotechnologies Stock Quote

Adaptive Biotechnologies (NASDAQ: ADPT)

Price as of September 28, 2023, 2:34 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Adaptive Biotechnologies Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ADPT -14.67% -72%
S&P +17.20% +46.69% +7.96% +47%

Adaptive Biotechnologies Company Info

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.